To overcome this limitation, we hypothesized that excess concentration of cell-permeable isocitrate, the substrate of IDH, would help treat DJ-1-associated PD by raising NADPH/NADP+ ratio to increase the reducing power in the cell. This evidence concerns the gene IDH1 and Parkinson disease.